October 19, 2021 07:23 AM EDT

Covid-19 roundup: FDA to give OK for mix-and-match booster shots — report; WHO group leads campaign to acquire antiviral drugs for $10

Josh Sullivan

The mix-and-match school of thought is picking up a victory as the FDA reportedly plans to allow Americans to receive a different Covid-19 booster than …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: FDA to give OK for mix-and-match booster shots — report; WHO group leads campaign to acquire antiviral drugs for $10

Josh Sullivan

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Why did Eli Lilly ask a patient on a compounded GLP-1 drug for their medical information?

FDA OKs the first-ever self-administered vaccine, for flu

The drug lobby's lawsuit against the IRA finds a sign of life after appeals court ruling

Biotech VC firm outlines plans for $100M fund

FTC to sue major PBMs over insulin rebates, claiming they inflated patient cost

Breaking down silos with a new quantitative approach to drug development

Covid-19 roundup: FDA to give OK for mix-and-match boost­er shots — re­port; WHO group leads cam­paign to ac­quire an­tivi­ral drugs for $10

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Covid-19 roundup: FDA to give OK for mix-and-match booster shots — report; WHO group leads campaign to acquire antiviral drugs for $10